What does CUSIP 40637H109 represent in this 13F holders report?

CUSIP 40637H109 is the security identifier for HALO - HALOZYME THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in Q2 2021?

309 institutional investors reported HALO - HALOZYME THERAPEUTICS, INC. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 118,494,184
Total 13F shares: 129,727,357
Share change: -2,036,817
Total reported value: $5,890,257,760
Put/Call ratio: 96%
Price per share: $45.41
Number of holders: 309
Value change: -$85,620,767
Number of buys: 147
Number of sells: 150

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 40637H109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	16%	18,437,478	$768,660,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	11%	13,257,866	$552,721,000	—	31 Mar 2021	13F
Artisan Partners Limited Partnership	13F	Company	8.8%	10,468,159	$436,418,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	4.7%	5,521,734	$230,201,000	—	31 Mar 2021	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	4.5%	5,337,462	$222,519,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	4.3%	5,119,082	$213,415,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	4.2%	5,033,216	$209,835,000	—	31 Mar 2021	13F
Bellevue Group AG	13F	Company	2.5%	3,011,966	$125,569,000	—	31 Mar 2021	13F
SNYDER CAPITAL MANAGEMENT L P	13F	Company	2.5%	2,920,860	$121,771,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.2%	2,624,709	$109,425,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.9%	2,267,258	$94,521,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	1.9%	2,240,279	$93,397,000	—	31 Mar 2021	13F
MACQUARIE GROUP LTD	13F	Company	1.9%	2,210,060	$92,138,000	—	31 Mar 2021	13F
First Light Asset Management, LLC	13F	Company	1.7%	2,011,350	$83,853,000	—	31 Mar 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	1.7%	1,981,256	$82,599,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	1.5%	1,808,366	$75,390,000	—	31 Mar 2021	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	1.5%	1,772,000	$75,185,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	1.4%	1,678,138	$69,962,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.3%	1,513,095	$63,081,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	1.2%	1,443,997	$60,199,000	—	31 Mar 2021	13F
TRAN CAPITAL MANAGEMENT, L.P.	13F	Company	1.1%	1,353,208	$56,415,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	1%	1,199,438	$50,005,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.97%	1,144,269	$47,705,000	—	31 Mar 2021	13F
Third Security, LLC	13F	Company	0.95%	1,129,551	$47,091,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.93%	1,101,570	$45,925,000	—	31 Mar 2021	13F
Stephens Investment Management Group LLC	13F	Company	0.92%	1,093,538	$45,590,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.92%	1,090,398	$45,459,000	—	31 Mar 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.91%	1,074,565	$44,799,000	—	31 Mar 2021	13F
GW&K Investment Management, LLC	13F	Company	0.9%	1,061,230	$44,243,000	—	31 Mar 2021	13F
Granite Investment Partners, LLC	13F	Company	0.77%	916,064	$38,191,000	—	31 Mar 2021	13F
Fisher Asset Management, LLC	13F	Company	0.76%	898,077	$37,441,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.75%	891,506	$37,166,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.73%	868,463	$36,207,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.73%	864,369	$36,036,000	—	31 Mar 2021	13F
Swedbank AB	13F	Company	0.71%	846,907	$35,307,553	—	31 Mar 2021	13F
HealthCor Management, L.P.	13F	Company	0.63%	745,605	$31,084,000	—	31 Mar 2021	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.62%	733,976	$30,599,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.62%	733,742	$30,102,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.59%	693,945	$28,930,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.58%	683,169	$28,481,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.57%	673,700	$28,087,000	—	31 Mar 2021	13F
Fiera Capital Corp	13F	Company	0.53%	622,153	$25,938,000	—	31 Mar 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.5%	594,212	$24,772,000	—	31 Mar 2021	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.47%	556,726	$23,210,000	—	31 Mar 2021	13F
Redwood Investments, LLC	13F	Company	0.46%	542,764	$22,628,000	—	31 Mar 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.41%	487,823	$20,338,000	—	31 Mar 2021	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.4%	476,681	$19,873,000	—	31 Mar 2021	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.38%	455,013	$18,969,000	—	31 Mar 2021	13F
Lombard Odier Asset Management (Switzerland) SA	13F	Company	0.38%	450,000	$18,761,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.37%	440,420	$18,361,000	—	31 Mar 2021	13F

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2021

As of 30 Jun 2021, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 309 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 129,727,357 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, Invesco Ltd., JPMORGAN CHASE & CO, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, MACQUARIE GROUP LTD, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 309 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

329

Q2 2021 holders

309

Holder diff

-20

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.